Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Journal of Neuroinflammation
Published in: Journal of Neuroinflammation 1/2017

Open Access 01-12-2017 | Research

Genetic effect of interleukin-1 beta (C-511T) polymorphism on the structural covariance network and white matter integrity in Alzheimer’s disease

Authors: Chi-Wei Huang, Shih-Wei Hsu, Shih-Jen Tsai, Nai-Ching Chen, Mu-En Liu, Chen-Chang Lee, Shu-Hua Huang, Weng-Neng Chang, Ya-Ting Chang, Wan-Chen Tsai, Chiung-Chih Chang

Published in: Journal of Neuroinflammation | Issue 1/2017

Login to get access

Abstract

Background

Inflammatory processes play a pivotal role in the degenerative process of Alzheimer’s disease. In humans, a biallelic (C/T) polymorphism in the promoter region (position-511) (rs16944) of the interleukin-1 beta gene has been significantly associated with differences in the secretory capacity of interleukin-1 beta. In this study, we investigated whether this functional polymorphism mediates the brain networks in patients with Alzheimer’s disease.

Methods

We enrolled a total of 135 patients with Alzheimer’s disease (65 males, 70 females), and investigated their gray matter structural covariance networks using 3D T1 magnetic resonance imaging and their white matter macro-structural integrities using fractional anisotropy. The patients were classified into two genotype groups: C-carriers (n = 108) and TT-carriers (n = 27), and the structural covariance networks were constructed using seed-based analysis focusing on the default mode network medial temporal or dorsal medial subsystem, salience network and executive control network. Neurobehavioral scores were used as the major outcome factors for clinical correlations.

Results

There were no differences between the two genotype groups in the cognitive test scores, seed, or peak cluster volumes and white matter fractional anisotropy. The covariance strength showing C-carriers > TT-carriers was the entorhinal-cingulum axis. There were two peak clusters (Brodmann 6 and 10) in the salience network and four peak clusters (superior prefrontal, precentral, fusiform, and temporal) in the executive control network that showed C-carriers < TT-carriers in covariance strength. The salience network and executive control network peak clusters in the TT group and the default mode network peak clusters in the C-carriers strongly predicted the cognitive test scores.

Conclusions

Interleukin-1 beta C-511 T polymorphism modulates the structural covariance strength on the anterior brain network and entorhinal-interconnected network which were independent of the white matter tract integrity. Depending on the specific C-511 T genotype, different network clusters could predict the cognitive tests.
Appendix
Available only for authorised users
Literature
1.
Dickson DW, Lee SC, Mattiace LA, Yen SH, Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer’s disease. Glia. 1993;7:75–83.CrossRefPubMed
2.
Holmes C, Cunningham C, Zotova E, Woolford J, Dean C, Kerr S, Culliford D, Perry VH. Systemic inflammation and disease progression in Alzheimer disease. Neurology. 2009;73:768–74.CrossRefPubMedPubMedCentral
3.
Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, Castellani RJ, Crain BJ, Davies P, Del Tredici K, et al. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol. 2012;71:362–81.CrossRefPubMedPubMedCentral
4.
Wirth M, Madison CM, Rabinovici GD, Oh H, Landau SM, Jagust WJ. Alzheimer’s disease neurodegenerative biomarkers are associated with decreased cognitive function but not beta-amyloid in cognitively normal older individuals. J Neurosci. 2013;33:5553–63.CrossRefPubMedPubMedCentral
5.
Candore G, Bulati M, Caruso C, Castiglia L, Colonna-Romano G, Di Bona D, Duro G, Lio D, Matranga D, Pellicano M, et al. Inflammation, cytokines, immune response, apolipoprotein E, cholesterol, and oxidative stress in Alzheimer disease: therapeutic implications. Rejuvenation Res. 2010;13:301–13.CrossRefPubMed
6.
Cevenini E, Caruso C, Candore G, Capri M, Nuzzo D, Duro G, Rizzo C, Colonna-Romano G, Lio D, Di Carlo D, et al. Age-related inflammation: the contribution of different organs, tissues and systems. How to face it for therapeutic approaches. Curr Pharm Des. 2010;16:609–18.CrossRefPubMed
7.
Di Bona D, Scapagnini G, Candore G, Castiglia L, Colonna-Romano G, Duro G, Nuzzo D, Iemolo F, Lio D, Pellicano M, et al. Immune-inflammatory responses and oxidative stress in Alzheimer’s disease: therapeutic implications. Curr Pharm Des. 2010;16:684–91.CrossRefPubMed
8.
Vasto S, Candore G, Duro G, Lio D, Grimaldi MP, Caruso C. Alzheimer’s disease and genetics of inflammation: a pharmacogenomic vision. Pharmacogenomics. 2007;8:1735–45.CrossRefPubMed
9.
Lynch MA. Interleukin-1 beta exerts a myriad of effects in the brain and in particular in the hippocampus: analysis of some of these actions. Vitam Horm. 2002;64:185–219.CrossRefPubMed
10.
Shaftel SS, Kyrkanides S, Olschowka JA, Miller JN, Johnson RE, O’Banion MK. Sustained hippocampal IL-1 beta overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology. J Clin Invest. 2007;117:1595–604.CrossRefPubMedPubMedCentral
11.
Ghosh S, Wu MD, Shaftel SS, Kyrkanides S, LaFerla FM, Olschowka JA, O’Banion MK. Sustained interleukin-1beta overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer’s mouse model. J Neurosci. 2013;33:5053–64.CrossRefPubMedPubMedCentral
12.
Hollegaard MV, Bidwell JL. Cytokine gene polymorphism in human disease: on-line databases, supplement 3. Genes Immun. 2006;7:269–76.CrossRefPubMed
13.
Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest. 1992;22:396–402.CrossRefPubMed
14.
Wang WF, Liao YC, Wu SL, Tsai FJ, Lee CC, Hua CS. Association of interleukin-I beta and receptor antagonist gene polymorphisms with late onset Alzheimer’s disease in Taiwan Chinese. Eur J Neurol. 2005;12:609–13.CrossRefPubMed
15.
Schneider H, Pitossi F, Balschun D, Wagner A, del Rey A, Besedovsky HO. A neuromodulatory role of interleukin-1beta in the hippocampus. Proc Natl Acad Sci U S A. 1998;95:7778–83.CrossRefPubMedPubMedCentral
16.
Barrientos RM, Sprunger DB, Campeau S, Watkins LR, Rudy JW, Maier SF. BDNF mRNA expression in rat hippocampus following contextual learning is blocked by intrahippocampal IL-1beta administration. J Neuroimmunol. 2004;155:119–26.CrossRefPubMed
17.
Huang CW, Chang WN, Lui CC, Chen CF, Lu CH, Wang YL, Chen C, Juang YY, Lin YT, Tu MC, Chang CC. Impacts of hyper-homocysteinemia and white matter hyper-intensity in Alzheimer’s disease patients with normal creatinine: an MRI-based study with longitudinal follow-up. Curr Alzheimer Res. 2010;7:527–33.CrossRefPubMed
18.
Tu MC, Huang CW, Chen NC, Chang WN, Lui CC, Chen CF, Chen C, Wang YL, Lin YT, Chang CC. Hyperhomocysteinemia in Alzheimer dementia patients and cognitive decline after 6 months follow-up period. Acta Neurol Taiwan. 2010;19:168–77.PubMed
19.
Chang YT, Chang CC, Lin HS, Huang CW, Chang WN, Lui CC, Lee CC, Lin YT, Chen CH, Chen NC. Montreal cognitive assessment in assessing clinical severity and white matter hyperintensity in Alzheimer’s disease with normal control comparison. Acta Neurol Taiwan. 2012;21:64–73.PubMed
20.
Deppe M, Duning T, Mohammadi S, Schwindt W, Kugel H, Knecht S, Ringelstein EB. Diffusion-tensor imaging at 3 T: detection of white matter alterations in neurological patients on the basis of normal values. Invest Radiol. 2007;42:338–45.CrossRefPubMed
21.
Hoth KF, Haley AP, Gunstad J, Paul RH, Poppas A, Jefferson AL, Tate DF, Ono M, Jerskey BA, Cohen RA. Elevated C-reactive protein is related to cognitive decline in older adults with cardiovascular disease. J Am Geriatr Soc. 2008;56:1898–903.CrossRefPubMedPubMedCentral
22.
Huang CW, Chang WN, Huang SH, Lui CC, Chen NC, Chang YT, Lee CC, Chang CC, Chang AY. Impact of homocysteine on cortical perfusion and cognitive decline in mild Alzheimer’s dementia. Eur J Neurol. 2013;20:1191–7.CrossRefPubMed
23.
Huang CW, Tsai MH, Chen NC, Chen WH, Lu YT, Lui CC, Chang YT, Chang WN, Chang AY, Chang CC. Clinical significance of circulating vascular cell adhesion molecule-1 to white matter disintegrity in Alzheimer’s dementia. Thromb Haemost. 2015;114:1230–40.CrossRefPubMed
24.
Raz N, Yang Y, Dahle CL, Land S. Volume of white matter hyperintensities in healthy adults: contribution of age, vascular risk factors, and inflammation-related genetic variants. Biochim Biophys Acta. 1822;2012:361–9.
25.
Zhang Z, Liu LJ, Zhang C, Yu YP. Association between Interleukin-1 gene single nucleotide polymorphisms and ischemic stroke classified by TOAST criteria in the Han population of northern China. Biomed Res Int. 2013;2013:961039.PubMedPubMedCentral
26.
Dziedzic T, Slowik A, Pera J, Szczudlik A. Interleukin 1 beta polymorphism (−511) and risk of stroke due to small vessel disease. Cerebrovasc Dis. 2005;20:299–303.CrossRefPubMed
27.
28.
Greicius MD, Srivastava G, Reiss AL, Menon V. Default-mode network activity distinguishes Alzheimer’s disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci U S A. 2004;101:4637–42.CrossRefPubMedPubMedCentral
29.
Greicius MD, Supekar K, Menon V, Dougherty RF. Resting-state functional connectivity reflects structural connectivity in the default mode network. Cereb Cortex. 2009;19:72–8.CrossRefPubMed
30.
Seeley WW, Allman JM, Carlin DA, Crawford RK, Macedo MN, Greicius MD, Dearmond SJ, Miller BL. Divergent social functioning in behavioral variant frontotemporal dementia and Alzheimer disease: reciprocal networks and neuronal evolution. Alzheimer Dis Assoc Disord. 2007;21:S50–57.CrossRefPubMed
31.
Seeley WW, Menon V, Schatzberg AF, Keller J, Glover GH, Kenna H, Reiss AL, Greicius MD. Dissociable intrinsic connectivity networks for salience processing and executive control. J Neurosci. 2007;27:2349–56.CrossRefPubMedPubMedCentral
32.
Agosta F, Pievani M, Geroldi C, Copetti M, Frisoni GB, Filippi M. Resting state fMRI in Alzheimer’s disease: beyond the default mode network. Neurobiol Aging. 2012;33:1564–78.CrossRefPubMed
33.
Filippi M, Agosta F, Scola E, Canu E, Magnani G, Marcone A, Valsasina P, Caso F, Copetti M, Comi G, et al. Functional network connectivity in the behavioral variant of frontotemporal dementia. Cortex. 2013;49:2389–401.CrossRefPubMed
34.
Andrews-Hanna JR, Reidler JS, Sepulcre J, Poulin R, Buckner RL. Functional-anatomic fractionation of the brain’s default network. Neuron. 2010;65:550–62.CrossRefPubMedPubMedCentral
35.
Jack Jr CR, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, Knopman DS, Shiung MM, Gunter JL, Boeve BF, Kemp BJ, et al. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer’s disease: implications for sequence of pathological events in Alzheimer’s disease. Brain. 2009;132:1355–65.CrossRefPubMedPubMedCentral
36.
Chhatwal JP, Schultz AP, Johnson K, Benzinger TL, Jack Jr C, Ances BM, Sullivan CA, Salloway SP, Ringman JM, Koeppe RA, et al. Impaired default network functional connectivity in autosomal dominant Alzheimer disease. Neurology. 2013;81:736–44.CrossRefPubMedPubMedCentral
37.
Hong SB, Zalesky A, Park S, Yang YH, Park MH, Kim B, Song IC, Sohn CH, Shin MS, Kim BN, et al. COMT genotype affects brain white matter pathways in attention-deficit/hyperactivity disorder. Hum Brain Mapp. 2015;36:367–77.CrossRefPubMed
38.
39.
Zeidan-Chulia F, de Oliveira BH, Salmina AB, Casanova MF, Gelain DP, Noda M, Verkhratsky A, Moreira JC. Altered expression of Alzheimer’s disease-related genes in the cerebellum of autistic patients: a model for disrupted brain connectome and therapy. Cell Death Dis. 2014;5:e1250.CrossRefPubMedPubMedCentral
40.
Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, et al. Revising the definition of Alzheimer’s disease: a new lexicon. Lancet Neurol. 2010;9:1118–27.CrossRefPubMed
41.
Chang CC, Kramer JH, Lin KN, Chang WN, Wang YL, Huang CW, Lin YT, Chen C, Wang PN. Validating the Chinese version of the Verbal Learning Test for screening Alzheimer’s disease. J Int Neuropsychol Soc. 2010;16:244–51.CrossRefPubMed
42.
Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A. Pathological verification of ischemic score in differentiation of dementias. Ann Neurol. 1980;7:486–8.CrossRefPubMed
43.
Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.CrossRefPubMed
44.
Teng EL, Hasegawa K, Homma A, Imai Y, Larson E, Graves A, Sugimoto K, Yamaguchi T, Sasaki H, Chiu D, et al. The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr. 1994;6:45–58. discussion 62.CrossRefPubMed
45.
Tsai SJ, Hong CJ, Liu ME, Hou SJ, Yen FC, Hsieh CH, Liou YJ. Interleukin-1 beta (C-511 T) genetic polymorphism is associated with cognitive performance in elderly males without dementia. Neurobiol Aging. 2010;31:1950–5.CrossRefPubMed
46.
Del Bo R, Comi GP, Bresolin N, Castelli E, Conti E, Degiuli A, Ausenda CD, Scarlato G. The apolipoprotein E epsilon4 allele causes a faster decline of cognitive performances in Down’s syndrome subjects. J Neurol Sci. 1997;145:87–91.CrossRefPubMed
47.
Wu MK, Lu YT, Huang CW, Lin PH, Chen NC, Lui CC, Chang WN, Lee CC, Chang YT, Chen SF, Chang CC. Clinical significance of cerebrovascular biomarkers and white matter tract integrity in Alzheimer disease: clinical correlations with neurobehavioral data in cross-sectional and after 18 months follow-ups. Medicine (Baltimore). 2015;94:e1192.CrossRefPubMedCentral
48.
Cuingnet R, Gerardin E, Tessieras J, Auzias G, Lehericy S, Habert MO, Chupin M, Benali H, Colliot O. Automatic classification of patients with Alzheimer’s disease from structural MRI: a comparison of ten methods using the ADNI database. Neuroimage. 2011;56:766–81.CrossRefPubMed
49.
Bernhardt BC, Worsley KJ, Besson P, Concha L, Lerch JP, Evans AC, Bernasconi N. Mapping limbic network organization in temporal lobe epilepsy using morphometric correlations: insights on the relation between mesiotemporal connectivity and cortical atrophy. Neuroimage. 2008;42:515–24.CrossRefPubMed
50.
51.
Zielinski BA, Anderson JS, Froehlich AL, Prigge MB, Nielsen JA, Cooperrider JR, Cariello AN, Fletcher PT, Alexander AL, Lange N, et al. scMRI reveals large-scale brain network abnormalities in autism. PLoS One. 2012;7:e49172.CrossRefPubMedPubMedCentral
52.
Nichols TE, Holmes AP. Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum Brain Mapp. 2002;15:1–25.CrossRefPubMed
53.
Hua K, Zhang J, Wakana S, Jiang H, Li X, Reich DS, Calabresi PA, Pekar JJ, van Zijl PC, Mori S. Tract probability maps in stereotaxic spaces: analyses of white matter anatomy and tract-specific quantification. Neuroimage. 2008;39:336–47.CrossRefPubMed
54.
55.
Green EK, Harris JM, Lemmon H, Lambert JC, Chartier-Harlin MC, St Clair D, Mann DM, Iwatsubo T, Lendon CL. Are interleukin-1 gene polymorphisms risk factors or disease modifiers in AD? Neurology. 2002;58:1566–8.CrossRefPubMed
56.
Ehl C, Kolsch H, Ptok U, Jessen F, Schmitz S, Frahnert C, Schlosser R, Rao ML, Maier W, Heun R. Association of an interleukin-1beta gene polymorphism at position −511 with Alzheimer’s disease. Int J Mol Med. 2003;11:235–8.PubMed
57.
Grimaldi LM, Casadei VM, Ferri C, Veglia F, Licastro F, Annoni G, Biunno I, De Bellis G, Sorbi S, Mariani C, et al. Association of early-onset Alzheimer’s disease with an interleukin-1alpha gene polymorphism. Ann Neurol. 2000;47:361–5.CrossRefPubMed
58.
Licastro F, Pedrini S, Ferri C, Casadei V, Govoni M, Pession A, Sciacca FL, Veglia F, Annoni G, Bonafe M, et al. Gene polymorphism affecting alpha1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer’s disease risk. Ann Neurol. 2000;48:388–91.CrossRefPubMed
59.
Ma SL, Tang NL, Lam LC, Chiu HF. Lack of association of the interleukin-1beta gene polymorphism with Alzheimer’s disease in a Chinese population. Dement Geriatr Cogn Disord. 2003;16:265–8.CrossRefPubMed
60.
Li XQ, Zhang JW, Zhang ZX, Chen D, Qu QM. Interleukin-1 gene cluster polymorphisms and risk of Alzheimer’s disease in Chinese Han population. J Neural Transm (Vienna). 2004;111:1183–90.
61.
Chen CH, Yang JH, Chiang CW, Hsiung CN, Wu PE, Chang LC, Chu HW, Chang J, Song IW, Yang SL, et al. Population structure of Han Chinese in the modern Taiwanese population based on 10,000 participants in the Taiwan Biobank project. Hum Mol Genet. 2016.
62.
Supekar K, Menon V, Rubin D, Musen M, Greicius MD. Network analysis of intrinsic functional brain connectivity in Alzheimer’s disease. PLoS Comput Biol. 2008;4:e1000100.CrossRefPubMedPubMedCentral
63.
Zhou J, Greicius MD, Gennatas ED, Growdon ME, Jang JY, Rabinovici GD, Kramer JH, Weiner M, Miller BL, Seeley WW. Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer’s disease. Brain. 2010;133:1352–67.CrossRefPubMedPubMedCentral
64.
Henderson ST, Poirier J. Pharmacogenetic analysis of the effects of polymorphisms in APOE, IDE and IL1B on a ketone body based therapeutic on cognition in mild to moderate Alzheimer’s disease: a randomized, double-blind, placebo-controlled study. BMC Med Genet. 2011;12:137.CrossRefPubMedPubMedCentral
65.
Benke KS, Carlson MC, Doan BQ, Walston JD, Xue QL, Reiner AP, Fried LP, Arking DE, Chakravarti A, Fallin MD. The association of genetic variants in interleukin-1 genes with cognition: findings from the cardiovascular health study. Exp Gerontol. 2011;46:1010–9.CrossRefPubMedPubMedCentral
66.
Tu PC, Su TP, Huang CC, Yang AC, Yeh HL, Hong CJ, Liou YJ, Liu ME, Lin CP, Tsai SJ. Interleukin-1 beta C-511 T polymorphism modulates functional connectivity of anterior midcingulate cortex in non-demented elderly Han males. Brain Struct Funct. 2014;219:61–9.CrossRefPubMed
67.
Meisenzahl EM, Rujescu D, Kirner A, Giegling I, Kathmann N, Leinsinger G, Maag K, Hegerl U, Hahn K, Moller HJ. Association of an interleukin-1beta genetic polymorphism with altered brain structure in patients with schizophrenia. Am J Psychiatry. 2001;158:1316–9.CrossRefPubMed
68.
Papiol S, Molina V, Desco M, Rosa A, Reig S, Sanz J, Palomo T, Fananas L. Gray matter deficits in bipolar disorder are associated with genetic variability at interleukin-1 beta gene (2q13). Genes Brain Behav. 2008;7:796–801.CrossRefPubMed
69.
Papiol S, Molina V, Rosa A, Sanz J, Palomo T, Fananas L. Effect of interleukin-1beta gene functional polymorphism on dorsolateral prefrontal cortex activity in schizophrenic patients. Am J Med Genet B Neuropsychiatr Genet. 2007;144B:1090–3.CrossRefPubMed
70.
Fatjo-Vilas M, Pomarol-Clotet E, Salvador R, Monte GC, Gomar JJ, Sarro S, Ortiz-Gil J, Aguirre C, Landin-Romero R, Guerrero-Pedraza A, et al. Effect of the interleukin-1beta gene on dorsolateral prefrontal cortex function in schizophrenia: a genetic neuroimaging study. Biol Psychiatry. 2012;72:758–65.CrossRefPubMed
71.
Persson N, Ghisletta P, Dahle CL, Bender AR, Yang Y, Yuan P, Daugherty AM, Raz N. Regional brain shrinkage over two years: individual differences and effects of pro-inflammatory genetic polymorphisms. Neuroimage. 2014;103:334–48.CrossRefPubMedPubMedCentral
72.
Fiandaca MS, Kapogiannis D, Mapstone M, Boxer A, Eitan E, Schwartz JB, Abner EL, Petersen RC, Federoff HJ, Miller BL, Goetzl EJ. Identification of preclinical Alzheimer’s disease by a profile of pathogenic proteins in neurally derived blood exosomes: a case-control study. Alzheimers Dement. 2015;11:600–7. e601.CrossRefPubMed
73.
Goetzl EJ, Boxer A, Schwartz JB, Abner EL, Petersen RC, Miller BL, Carlson OD, Mustapic M, Kapogiannis D. Low neural exosomal levels of cellular survival factors in Alzheimer’s disease. Ann Clin Transl Neurol. 2015;2:769–73.CrossRefPubMedPubMedCentral
74.
Goetzl EJ, Boxer A, Schwartz JB, Abner EL, Petersen RC, Miller BL, Kapogiannis D. Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease. Neurology. 2015;85:40–7.CrossRefPubMedPubMedCentral
75.
Baune BT, Ponath G, Rothermundt M, Riess O, Funke H, Berger K. Association between genetic variants of IL-1beta, IL-6 and TNF-alpha cytokines and cognitive performance in the elderly general population of the MEMO-study. Psychoneuroendocrinology. 2008;33:68–76.CrossRefPubMed
76.
Sasayama D, Hori H, Teraishi T, Hattori K, Ota M, Matsuo J, Kawamoto Y, Kinoshita Y, Higuchi T, Amano N, Kunugi H. Association of interleukin-1beta genetic polymorphisms with cognitive performance in elderly females without dementia. J Hum Genet. 2011;56:613–6.CrossRefPubMed
77.
Lau S, Bates KA, Sohrabi HR, Rodrigues M, Martins G, Dhaliwal SS, Taddei K, Laws SM, Martins IJ, Mastaglia FL, et al. Functional effects of genetic polymorphism in inflammatory genes in subjective memory complainers. Neurobiol Aging. 2012;33:1054–6.CrossRefPubMed
78.
Marioni RE, Deary IJ, Murray GD, Fowkes FG, Price JF. Associations between polymorphisms in five inflammation-related genes and cognitive ability in older persons. Genes Brain Behav. 2010;9:348–52.CrossRefPubMed
79.
Beckmann CF, DeLuca M, Devlin JT, Smith SM. Investigations into resting-state connectivity using independent component analysis. Philos Trans R Soc Lond B Biol Sci. 2005;360:1001–13.CrossRefPubMedPubMedCentral
Metadata
Title
Genetic effect of interleukin-1 beta (C-511T) polymorphism on the structural covariance network and white matter integrity in Alzheimer’s disease
Authors
Chi-Wei Huang
Shih-Wei Hsu
Shih-Jen Tsai
Nai-Ching Chen
Mu-En Liu
Chen-Chang Lee
Shu-Hua Huang
Weng-Neng Chang
Ya-Ting Chang
Wan-Chen Tsai
Chiung-Chih Chang
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Journal of Neuroinflammation / Issue 1/2017
Electronic ISSN: 1742-2094
DOI
https://doi.org/10.1186/s12974-017-0791-z

Other articles of this Issue 1/2017

Journal of Neuroinflammation 1/2017 Go to the issue

Research

Increased frequency of IL-6-producing non-classical monocytes in neuromyelitis optica spectrum disorder

Research

Prenatal alcohol exposure is a risk factor for adult neuropathic pain via aberrant neuroimmune function

Research

Fluoxetine-enhanced autophagy ameliorates early brain injury via inhibition of NLRP3 inflammasome activation following subarachnoid hemorrhage in rats

Research

Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis

Research

Selective depletion of microglial progranulin in mice is not sufficient to cause neuronal ceroid lipofuscinosis or neuroinflammation

Research

Neuronal CCL2 expression drives inflammatory monocyte infiltration into the brain during acute virus infection